Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities

Cancer Investigation

Volumn 30, Issue 6, 2012, Pages 473-480

  Shigetomi, Hiroshi ^a   Tsunemi, Taihei ^a   Haruta, Shoji ^a   Kajihara, Hirotaka ^a   Yoshizawa, Yoriko ^a   Tanase, Yasuhito ^a   Furukawa, Naoto ^a   Yoshida, Shozo ^a   Sado, Toshiyuki ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Endometriosis; Inflammation; Iron; Ovarian cancer; Oxidative stress

Indexed keywords

AT RICH INTERACTIVE DOMAIN 1A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; DNA METHYLATION; ENDOMETRIOSIS; GENE MUTATION; GENE TARGETING; GENOMIC INSTABILITY; HUMAN; INFLAMMATION; MOLECULAR GENETICS; OVARY CARCINOMA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, CLEAR CELL; ANTIOXIDANTS; ENDOMETRIOSIS; FEMALE; HUMANS; INFLAMMATION; OVARIAN NEOPLASMS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84861746066     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.681821     Document Type: Article

References (53)

1. Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am J Surg Pathol 2010;34:433-443.
2. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP. Tubal and ovarian pathways to pelvic epithelial cancer: A pathological perspective. Histopathology 2008;53:127-138. (Pubitemid 352032762)
3. Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A, Bowtell D, Brenton JD. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 2010;221:49-56.
4. Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, Morioka E, Arisawa K, Terao T. Risk of developing ovarian cancer among women with ovarian endometrioma: A cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007;17:37-43. (Pubitemid 46213967)
5. Kobayashi H, SumimotoK, Kitanaka T, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Terao T. Ovarian endometrioma-risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol 2008;138:187-193.
6. Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 2008;14:32-40. (Pubitemid 351377975)
7. Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T, Oi H. The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol 2009;25:39-52.
8. MandaiM, Yamaguchi K,Matsumura N, Baba T, Konishi I. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 2009;14:383-391.
9. Kobayashi H, Kajiwara H, Kanayama S, Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, SakataM, SadoT,OiH.Molecular pathogenesis of endometriosis-Associated clear cell carcinoma of the ovary (review). Oncol Rep 2009;22:233-240.
10. Maor I, Rainis T, Lanir A, Lavy A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: Distinction between active and non-Active disease. Dig Dis Sci 2008;53:2208-2214.
11. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995;358:1-3.
12. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999;91:1459-1467. (Pubitemid 29424550)
13. Altinoz MA, Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 2004;51:239-247. (Pubitemid 38915539)
14. KhanKN, KitajimaM, Hiraki K, YamaguchiN,Katamine S,Matsuyama T, Nakashima M, Fujishita A, Ishimaru T, Masuzaki H. Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. Fertil Steril 2010;94:2860-3.e1-3.
15. Haider S, Kn̈ofler M. Human tumour necrosis factor: Physiological and pathological roles in placenta and endometrium. Placenta 2009;30:111-123.
16. Shan W, Liu J. Epithelial ovarian cancer: Focus on genetics and animal models. Cell Cycle 2009;8:731-735.
17. KatohM, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 2007;13:4042-4045. (Pubitemid 47105963)
18. Zhao C, Wu LS, Barner R. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: Clinicopathologic features of tumorswith endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2011;2:94-106.
19. Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006;19:83-89. (Pubitemid 43250982)
20. Yamada Y, Shigetomi H, Onogi A, Haruta S, Kawaguchi R, Yoshida S, Furukawa N, Nagai A, Tanase Y, Tsunemi T, Oi H, Kobayashi H. New insights into pattern recognition receptors and their ligands in gynecologic pathologies. Hum Immunol 2011;72:213-218.
21. Jones S, Wang TL, Shih, IeM, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz La Jr, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos N. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010;330:228-231.
22. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N,Aparicio SA, Shih, IeM,Mes-Masson AM, BowtellDD, Hirst M, Gilks B,Marra MA,HuntsmanDG. ARID1Amutations in endometriosis-Associated ovarian carcinomas. N Engl J Med 2010;363:1532-1543.
23. Yamamoto S, Tsuda H, Takano M, Iwaya K, Tamai S, Matsubara O. PIK3CA mutation is an early event in the development of endometriosis-Associated ovarian clear cell adenocarcinoma. J Pathol 2011; doi: 10.1002/path.2940.
24. Kato N, Tamura G,Motoyama T. Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary. Virchows Arch 2008;452:175-180.
25. ShigetomiH,OonogiA, Tsunemi T, Tanase Y, Yamada Y,Kajihara H, Yoshizawa Y, Furukawa N, Haruta S, Yoshida S, Sado T, Oi H, Kobayashi H. The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary. Oncol Lett 2011; 2, 591-597.
26. Flores-Alcantar A, Gonzalez-Sandoval A, Escalante-Alcalde D, Lomeĺi H. Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle. Cell Tissue Res 2011;345:137-148.
27. LiXS, Trojer P,MatsumuraT,TreismanJE, TaneseN.Mammalian SWI/SNF-A subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Mol Cell Biol 2010;30:1673-1688.
28. Serra V,Markman B, ScaltritiM, Eichhorn PJ, Valero V, Guzman M, Botero ML, Llonch E, Atzori F, Di Cosimo S,MairaM, Garcia-Echeverria C, Parra JL, Arribas J, Baselga J. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3Kmutations. Cancer Res 2008;68:8022-8030.
29. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004;304:554. (Pubitemid 38541907)
30. Ligresti G, Militello L, Steelman LS,CavallaroA, Basile F,Nicoletti F, Stivala F,McCubrey JA, LibraM. PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches. Cell Cycle 2009; 8:1352-1358.
31. Zhang X, Deng HX, Zhao X, Su D, Chen XC, Chen LJ, Wei YQ, Zhong Q, Li ZY,He X, Yi T. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo. Oncology 2009;77:22-32.
32. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40. (Pubitemid 43227479)
33. Mier-Cabrera J, Jiḿenez-Zamudio L, Garćia-Latorre E, Cruz-Orozco O, Herńandez-Guerrero C. Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stressassociated characteristics in women with minimal and mild endometriosis. BJOG 2011;118:6-16.
34. Campbell IG, Thomas EJ. Endometriosis: Candidate genes. Hum Reprod Update 2001;7:15-20. (Pubitemid 32111962)
35. Okada S, Hamazaki S, Toyokuni S, Midorikawa O. Induction of mesothelioma by intraperitoneal injections of ferric saccharate in maleWistar rats. Br J Cancer 1989;60:708-711. (Pubitemid 19275735)
36. Wang SJ, Gao C, Chen BA. Advancement of the study on iron metabolism and regulation in tumor cells. Chin J Cancer 2010;29:451-455.
37. Wang Z, Wijewickrama GT, Peng KW, Dietz BM, Yuan L, van Breemen RB, Bolton JL,Thatcher GR. Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen CatecholMetabolite to the Nucleus. J Biol Chem 2009;284:8633-8642.
38. Zhang QG, Raz L, Wang R, Han D, De Sevilla L, Yang F, Vadlamudi RK, Brann DW. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci 2009;29:13823-13836.
39. Akahane T, Sekizawa A, Okuda T, Kushima M, Saito H, Okai T. Disappearance of steroid hormone dependency during malignant transformation of ovarian clear cell cancer. Int J Gynecol Pathol 2005;24:369-376. (Pubitemid 41368291)
40. Tamir S, Izrael S, Vaya J. The effect of oxidative stress on ERalpha and ERbeta expression. J Steroid Biochem Mol Biol 2002;81:327-332. (Pubitemid 35279117)
41. Defr̀ere S, Gonźalez-Ramos R, Lousse JC, Colette S, Donnez O, Donnez J, Van Langendonckt A. Insights into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol 2011;26:1083-1092.
42. Brookes MJ, Boult J, Roberts K, Cooper BT, Hotchin NA, Matthews G, Iqbal T, Tselepis C. A role for iron inWnt signalling. Oncogene 2008;27:966-975.
43. Yang C, Ling H, Zhang M, Yang Z, Wang X, Zeng F, Wang C, Feng J. Oxidative stress mediates chemical hypoxia-induced injury and inflammation by activating NF-?b-COX-2 pathway in HaCaT cells. Mol Cells 2011;31:531-538.
44. White KL, RiderDN, Kalli KR, Knutson KL, Jarvik GP, Goode EL. Genomics of the NF-?B signaling pathway: Hypothesized role in ovarian cancer. Cancer Causes Control 2011;22:785-801.
45. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572-579. (Pubitemid 27147164)
46. Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol 2010;202:514-521.
47. Sarkar FH, Li Y,Wang Z, Kong D. NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 2008;27:293-319.
48. Subudhi U, Das K, Paital B, Bhanja S, Chainy GB. Supplementation of curcumin and vitamin E enhances oxidative stress, but restores hepatic histoarchitecture in hypothyroid rats. Life Sci 2009;84:372-379.
49. List AF. Iron overload in myelodysplastic syndromes: Diagnosis and management. Cancer Control 2010;17(Suppl):2-8.
50. Hider RC, Roy S,Ma YM, Le Kong X, Preston J.The potential application of iron chelators for the treatment of neurodegenerative diseases. Metallomics 2011;3:239-49.
51. Drisko JA, Chapman J, Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr 2003;22:118-123. (Pubitemid 36417825)
52. Galaris D, Skiada V, Barbouti A. Redox signaling and cancer: The role of "labile" iron. Cancer Lett 2008;266:21-29.
53. Lin J, Zhang X, Chen Y. Mutagen sensitivity as a susceptibility marker for endometriosis. Hum Reprod 2003;18:2052-2057. (Pubitemid 37265065)